Cargando…

Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), characterized by infiltrating inflammatory cells and demyelinating lesions, and T helper (Th) cells play critical roles in the pathogenesis of MS. There is still lack of effective treatments currently. Pien Tze Hua...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xuemei, Guo, Qingqing, Liu, Xue, Luo, Hui, Fan, Danping, Deng, Yongqi, Cui, Hua, Lu, Cheng, Zhang, Ge, He, Xiaojuan, Lu, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220046/
https://www.ncbi.nlm.nih.gov/pubmed/30429789
http://dx.doi.org/10.3389/fphar.2018.01237
_version_ 1783368749576880128
author Qiu, Xuemei
Guo, Qingqing
Liu, Xue
Luo, Hui
Fan, Danping
Deng, Yongqi
Cui, Hua
Lu, Cheng
Zhang, Ge
He, Xiaojuan
Lu, Aiping
author_facet Qiu, Xuemei
Guo, Qingqing
Liu, Xue
Luo, Hui
Fan, Danping
Deng, Yongqi
Cui, Hua
Lu, Cheng
Zhang, Ge
He, Xiaojuan
Lu, Aiping
author_sort Qiu, Xuemei
collection PubMed
description Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), characterized by infiltrating inflammatory cells and demyelinating lesions, and T helper (Th) cells play critical roles in the pathogenesis of MS. There is still lack of effective treatments currently. Pien Tze Huang (PZH), a traditional Chinese medicine formula, has been proved to have anti-inflammatory, neuroprotective, and immunoregulatory effects. However, whether PZH can be used to treat MS is still obscure. This study aimed to investigate the possible therapeutic effect and the underlying action mechanism of PZH in relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE) mice. Female SJL/J mice were immunized with myelin proteolipid protein 139–151 (PLP(139−151)) and pertussis toxin to establish RR-EAE model. Mice were then randomly divided into normal group, model group, PZH group and positive control group (fingolimod, FTY-720), and drugs were orally administered for 60 days from the day 10 after immunization. Sera of mice were collected for ELISA detection. Tissues of CNS were harvested for hematoxylin-eosin (H-E) and luxol fast blue (LFB) staining. Furthermore, Th1, Th17 cells and their related cytokines in the CNS were detected by flow cytometry and quantitative real-time PCR, respectively. Proteins involved in STAT and NF-κB signaling pathways were detected by western blot. The results showed that PZH-treated mice displayed mild or moderate clinical symptoms compared with untreated EAE mice that exhibited severe clinical symptoms. PZH remarkably reduced inflammatory cell infiltration and myelin damage in the CNS of EAE mice. It markedly down-regulated the levels of IFN-γ and IL-17A in sera of EAE mice. Moreover, PZH could reduce the percentages of Th1 and Th17 cells. It also suppressed the production of transcription factors ROR-γt and T-bet as well as the mRNA levels of their downstream pro-inflammatory cytokines, such as IFN-γ and IL-17A. Furthermore, PZH could inhibit the phosphorylation of some key proteins in the STAT and NF-κB signaling pathways. In conclusion, the study demonstrated that PZH had a therapeutic effect on RR-EAE mice, which was associated with the modulation effect on Th1 and Th17 cells.
format Online
Article
Text
id pubmed-6220046
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62200462018-11-14 Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells Qiu, Xuemei Guo, Qingqing Liu, Xue Luo, Hui Fan, Danping Deng, Yongqi Cui, Hua Lu, Cheng Zhang, Ge He, Xiaojuan Lu, Aiping Front Pharmacol Pharmacology Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), characterized by infiltrating inflammatory cells and demyelinating lesions, and T helper (Th) cells play critical roles in the pathogenesis of MS. There is still lack of effective treatments currently. Pien Tze Huang (PZH), a traditional Chinese medicine formula, has been proved to have anti-inflammatory, neuroprotective, and immunoregulatory effects. However, whether PZH can be used to treat MS is still obscure. This study aimed to investigate the possible therapeutic effect and the underlying action mechanism of PZH in relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE) mice. Female SJL/J mice were immunized with myelin proteolipid protein 139–151 (PLP(139−151)) and pertussis toxin to establish RR-EAE model. Mice were then randomly divided into normal group, model group, PZH group and positive control group (fingolimod, FTY-720), and drugs were orally administered for 60 days from the day 10 after immunization. Sera of mice were collected for ELISA detection. Tissues of CNS were harvested for hematoxylin-eosin (H-E) and luxol fast blue (LFB) staining. Furthermore, Th1, Th17 cells and their related cytokines in the CNS were detected by flow cytometry and quantitative real-time PCR, respectively. Proteins involved in STAT and NF-κB signaling pathways were detected by western blot. The results showed that PZH-treated mice displayed mild or moderate clinical symptoms compared with untreated EAE mice that exhibited severe clinical symptoms. PZH remarkably reduced inflammatory cell infiltration and myelin damage in the CNS of EAE mice. It markedly down-regulated the levels of IFN-γ and IL-17A in sera of EAE mice. Moreover, PZH could reduce the percentages of Th1 and Th17 cells. It also suppressed the production of transcription factors ROR-γt and T-bet as well as the mRNA levels of their downstream pro-inflammatory cytokines, such as IFN-γ and IL-17A. Furthermore, PZH could inhibit the phosphorylation of some key proteins in the STAT and NF-κB signaling pathways. In conclusion, the study demonstrated that PZH had a therapeutic effect on RR-EAE mice, which was associated with the modulation effect on Th1 and Th17 cells. Frontiers Media S.A. 2018-10-31 /pmc/articles/PMC6220046/ /pubmed/30429789 http://dx.doi.org/10.3389/fphar.2018.01237 Text en Copyright © 2018 Qiu, Guo, Liu, Luo, Fan, Deng, Cui, Lu, Zhang, He and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Qiu, Xuemei
Guo, Qingqing
Liu, Xue
Luo, Hui
Fan, Danping
Deng, Yongqi
Cui, Hua
Lu, Cheng
Zhang, Ge
He, Xiaojuan
Lu, Aiping
Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title_full Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title_fullStr Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title_full_unstemmed Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title_short Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
title_sort pien tze huang alleviates relapsing-remitting experimental autoimmune encephalomyelitis mice by regulating th1 and th17 cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220046/
https://www.ncbi.nlm.nih.gov/pubmed/30429789
http://dx.doi.org/10.3389/fphar.2018.01237
work_keys_str_mv AT qiuxuemei pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT guoqingqing pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT liuxue pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT luohui pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT fandanping pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT dengyongqi pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT cuihua pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT lucheng pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT zhangge pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT hexiaojuan pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells
AT luaiping pientzehuangalleviatesrelapsingremittingexperimentalautoimmuneencephalomyelitismicebyregulatingth1andth17cells